Physician

Jonathan Barrett Robinson, MD

According to 2025 Medicare claims, Jonathan Robinson, MD (NPI: 1891286589) practices family practice in the Oklahoma City, OK market, with the plurality of this provider's patient population coming from Cleveland, OK. This provider's primary affiliated billing organization is OKLAHOMA ARTHRITIS CENTER, P.C. (NPI: 1528036019; TIN: 731578116) and primary practice location at 73013-3084. Robinson is affiliated with the Mercy Health ACO, LLC (ACO ID: A2616) and Lifecare ACO LLC (ACO ID: A3644), participating under the MSSP model.

Robinson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 338 traditional Medicare patients, billed 122,414 HCPCS/CPT codes, and received $1,799,817 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,348 prescription claims across 279 beneficiaries totaling $2,219,401 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 11 records totaling $745. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,817 to $2,219,401. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$900K$1.8M2021 Medicare payment: $6,825 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $55,891 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $71,894 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,799,817 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202131259$6,825
20221652,708$55,891
20232304,123$71,894
2024338122,414$1,799,817

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.2M2020 Drug cost: $1,817 (USD; Tot_Drug_Cst)2021 Drug cost: $14,027 (USD; Tot_Drug_Cst)2022 Drug cost: $498,981 (USD; Tot_Drug_Cst)2023 Drug cost: $1,420,908 (USD; Tot_Drug_Cst)2024 Drug cost: $2,219,401 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201660$1,817
202148140$14,027
2022131794$498,981
20232391,653$1,420,908
20242792,348$2,219,401

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more190466$85
80053Blood test, comprehensive group of blood chemicals179292$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count174291$7
86140Measurement c-reactive protein for detection of infection or inflammation188325$5
85652Red blood cell sedimentation rate, to detect inflammation, automated161262$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab1263,526$1,125,885
Cosentyx Sensoready PenSecukinumab17476$150,004
BenlystaBelimumab421,120$141,284
Orencia ClickjectAbatacept25700$141,088
Actemra ActpenTocilizumab23645$88,332

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.11$745Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jonathan Barrett Robinson, MD?

Tedicare shows public-source Medicare data for Jonathan Barrett Robinson, MD (NPI 1891286589), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jonathan Barrett Robinson, MD have ACO affiliation data?

Jonathan Barrett Robinson, MD is shown with ACO affiliation data for Mercy Health ACO, LLC (MSSP, ACO ID A2616) and Lifecare ACO LLC (MSSP, ACO ID A3644).

What billing organization is linked to Jonathan Barrett Robinson, MD?

Jonathan Barrett Robinson, MD is linked to OKLAHOMA ARTHRITIS CENTER, P.C. (billing NPI 1528036019) in the available physician profile data.

Does Jonathan Barrett Robinson, MD have Open Payments data?

Jonathan Barrett Robinson, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.